Nazila Safari

Learn More
BACKGROUND Chronic myelogenous leukemia (CML) is a kind of hematopoietic stem-cell cancer. A significant number of CML patients who do not achieve an acceptable response to therapy, show acquired resistance against Imatinib. One of the most considerable causes of resistance against Imatinib as the first line of therapy, are BCR-ABL kinase domain mutations.(More)
  • Hr Basseri, N Safari, Sh Mousakazemi, K Akbarzade
  • 2004
Lectins that agglutinate red blood cells (RBCs) were demonstrated in Anopheles stephensi mosquito midgut extracts using human (four groups: A, B, AB and O, RH+) rat, sheep and rabbit blood cells. Only rabbit RBCs showed agglutination reaction against the midgut extracts. Significant differences in hemagglutinin titers and carbohydrate specifity were(More)
BACKGROUND Although catalytic properties of different genetic polymorphisms of VKORC1 and CYP2C9 products have been identified, there is limited study available regarding warfarin dose requirement in Iranian patient population. This study investigates the impact of these polymorphisms on 115 patients, referred to Payvand Clinical and Specialty Laboratory(More)
  • 1